Your browser doesn't support javascript.
loading
Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma.
Eckhardt, Alicia; Drexler, Richard; Schoof, Melanie; Struve, Nina; Capper, David; Jelgersma, Claudius; Onken, Julia; Harter, Patrick N; Weber, Katharina J; Divé, Iris; Rothkamm, Kai; Hoffer, Konstantin; Klumpp, Lukas; Ganser, Katrin; Petersen, Cordula; Ricklefs, Franz; Kriegs, Malte; Schüller, Ulrich.
Afiliación
  • Eckhardt A; Department of Radiotherapy & Radiation Oncology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Drexler R; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.
  • Schoof M; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Struve N; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Capper D; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.
  • Jelgersma C; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Onken J; Department of Radiotherapy & Radiation Oncology, Hubertus Wald Tumor Center - University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Harter PN; Mildred-Scheel Cancer Career Center HATRICs4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Weber KJ; Department of Neuropathology, Charité University Medicine Berlin, Berlin, Germany.
  • Divé I; Department of Neurosurgery, Charité University Medicine Berlin, Berlin, Germany.
  • Rothkamm K; Department of Neurosurgery, Charité University Medicine Berlin, Berlin, Germany.
  • Hoffer K; German Cancer Consortium (DKTK), Partner Site Berlin, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Klumpp L; Neurological Institute (Edinger Institute), University Hospital, Frankfurt am Main, Germany.
  • Ganser K; German Cancer Consortium (DKTK), Heidelberg, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Petersen C; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
  • Ricklefs F; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Kriegs M; Neurological Institute (Edinger Institute), University Hospital, Frankfurt am Main, Germany.
  • Schüller U; German Cancer Consortium (DKTK), Heidelberg, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Neuro Oncol ; 26(3): 503-513, 2024 03 04.
Article en En | MEDLINE | ID: mdl-37818983
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Alemania